Periodic Reporting for period 2 - SKLCarbonP2 (Project: Scale up of CDC production for inclusion in ultracapacitor to double the performance.)
Periodo di rendicontazione: 2017-04-01 al 2018-06-30
Skeleton Technologies (SKL) has developed a patented carbide derived carbon (CDC) ultracapacitor technology, which enables a four-fold increase in power density and twice the energy density and, approximately halves the cost/performance ratio. Contingent on the specific application, in most cases the economic impact of an ultracapacitor based energy solution returns its value more than ten-fold over its lifetime as monetary savings in energy consumption and reduces emissions accordingly.
The technological challenge of the project lies with scaling CDC production from TRL 6 by deploying large-scale fluidized bed reactors at a certified chemical manufacturing site to achieve TRL 8.